Substance

LIRAGLUTIDE

Global reference: every product and company linked to this substance.

LIRAGLUTIDE (GENETICAL RECOMBINATION) · liraglutide [INN] · LIRAGLUTIDE [JAN] · LIRAGLUTIDE [USAN] · Liraglutide [WHO-DD] · NN-2211 · NN-9924 · NN2211 · NN9924 · NNC 90-1170 · NNC-90-1170 · SAXENDA

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (4)

  • LIRAGLUTIDE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
  • SAXENDA · NOVO NORDISK A/S COMMON STOCK
  • VICTOZA · NOVO NORDISK A/S COMMON STOCK
  • XULTOPHY 100/3.6 · NOVO NORDISK A/S COMMON STOCK

Companies holding this asset (3)